SALT treatment for liver cirrhosis and liver cancer
Part of Cancer, Digestive system clinical trials.
This trial is testing a treatment called SALT for people with liver cirrhosis and a specific type of liver cancer (HCC) caused by hepatitis B. It aims to help patients whose tumors are limited in size and number.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your liver disease is at a moderate stage (Child-Pugh A or B).
- You have liver cirrhosis and a liver cancer (HCC) caused by hepatitis B.
- The total size (in centimeters) and number of liver tumors add up to 7 or less.
- You are generally active and able to care for yourself (performance status 0-1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called SALT for people with cirrhosis from hepatitis B who have serious complications. It aims to see if SALT can help improve outcomes for those who may need a liver transplant.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This trial tests whether a liver transplant plus salt solution (a special preservation fluid) can help people with colorectal cancer that has spread to the liver but cannot be surgically removed. The goal is to see if this approach can stop cancer growth and improve survival.
This trial tests a new way to transplant livers in teenagers with severe liver disease who cannot get a standard living donor transplant. It aims to see if a special type of transplant (called SALT) can help them get the liver they need.
This trial tests a targeted radiation treatment (SIRT) for people with liver cancer that is still confined to one side of the liver and has not been treated before. The goal is to see if SIRT can shrink the tumor enough to make surgical removal possible.
This trial tests if removing the main liver tumor with surgery, followed by targeted therapy and immunotherapy, can help people with advanced liver cancer that has spread a little. It is for those who have not had prior treatment and whose liver is still working well.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.